{"schema_version":"secwatch.filing_event.v1","accession":"0001048477-25-000086","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2025-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.197040+00:00","generated_at":"2026-05-17T21:43:34.241568+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BioMarin appoints Ian T. Clark to Board of Directors effective August 1, 2025","bullets":["Board size increased from ten to eleven members to accommodate Clark's appointment.","Clark appointed to Audit Committee and Science and Technology Committee.","Received RSU grant valued at $400,000 under 2017 Equity Incentive Plan.","Will receive standard non-employee director fees and committee retainers as outlined in proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001048477-25-000086","json":"https://secwatch.observer/filing/0001048477-25-000086.json","markdown":"https://secwatch.observer/filing/0001048477-25-000086.md","text":"https://secwatch.observer/filing/0001048477-25-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000086/0001048477-25-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000086/bmrn-20250730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:43:34.241568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}